BridgeBio Pharma, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
BridgeBio Pharma, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2017 to Q4 2023.
  • BridgeBio Pharma, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $30.9M, a 14.2% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $30.9M +$3.84M +14.2% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $27M +$5.76M +27.1% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $21.3M +$8.73M +69.7% Dec 31, 2021 10-K 2024-02-22
Q4 2020 $12.5M +$4.92M +64.7% Dec 31, 2020 10-K 2023-02-23
Q4 2019 $7.6M +$6.42M +543% Dec 31, 2019 10-K 2022-02-25
Q4 2018 $1.18M +$886K +299% Dec 31, 2018 10-K 2021-02-25
Q4 2017 $296K Dec 31, 2017 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.